The identification of drug-resistant cancer stem cells (cr-CSCs) originated from research on colon cancer cells resistant to chemotherapy, which maintain their resistance through autocrine interleukin-4 (IL-4) signaling to increase anti-apoptotic protein expression (Todaro et al., 2007). Here, IL4 is linked to malignant colon neoplasm.